SuperworthGT Biopharma market cap GTBP
Share price times shares outstanding: what the whole company sells for, since 2016.
- Today, Oct 23, 2026
- $9.9M
- Highest close in our data
- $469.9M
- May 2021
GT Biopharma is worth $9.9M at the close on Oct 23, 2026, at $5.46 a share.
That is up 305% over the last year and down 95% over five years.
Its highest close in our data was $469.9M in May 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $9.9M | $4.9M | $18.5M | +11% |
| 2025 | $8.9M | $2.2M | $9.2M | +31% |
| 2024 | $6.7M | $3M | $10.5M | −36% |
| 2023 | $10.6M | $9M | $34M | −63% |
| 2022 | $28.8M | $28.8M | $98.5M | −69% |
| 2021 | $93.3M | $22.6M | $469.9M | +181% |
| 2020 | $33.2M | $6.1M | $45.2M | +407% |
| 2019 | $6.5M | $6.1M | $42.2M | −81% |
| 2018 | $33.7M | $31.2M | $221M | −85% |
| 2017 | $221.5M | $8.3K | $268.7M | +7532% |
| 2016 | $2.9M | $1.7M | $13M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest GT Biopharma's size, closest first, today.
| Company | Market cap |
|---|---|
| GTBPGT Biopharma | $9.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on GT Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.